Abstract

Lithostathine (pancreatic stone protein, Reg protein) is, in addition to albumin, the major nonenzymatic protein of the pancreatic juice. It has been assumed to inhibit calcium carbonate precipitation and therefore to prevent stone formation in the pancreatic ducts. This function is, however, debatable. The assumption is based on the inhibition of in vitro crystal nucleation and growth by lithostathine. Considering that these phenomena occur only under certain critical conditions, we re-examined the question using a protein preparation where the purity and folding have been tested by mass spectroscopy and NMR in the absence of nonprotein contaminants. Under these conditions, we showed conclusively that lithostathine does not inhibit calcium carbonate nucleation and crystal growth. We demonstrated that previous findings on the alleged inhibition can be attributed to the uncontrolled presence of salts in the protein preparation used. Moreover, the affinity of lithostathine to calcite crystals, expressed as the half-life of bound iodinated protein in the presence of unlabeled competitor, was significantly lower than that of bovine serum albumin (8.8 and 11.2 h, respectively). Using glass microspheres instead of crystals did not significantly change the half-life of bound lithostathine (8.0 h). These findings are incompatible with the hypothesis of a specific interaction of lithostathine with calcium carbonate crystals. In conclusion, considering that components of pancreatic juice such as NaCl and phosphate ions are powerful inhibitors of calcium carbonate crystal growth, the mechanism of stone formation in pancreatic ducts must be reconsidered. The presence in normal pancreatic juice of small amounts of the 133-residue isoform of lithostathine (PSP-S1), which precipitates at physiological pH, should be noted, and the possibility should be considered that they form micro-precipitates that aggregate and are progressively calcified.

Highlights

  • Lithostathine or Reg protein is a 144-residue glycoprotein synthesized by the exocrine pancreas [1, 2]

  • Phosphate was introduced by dialysis of the protein solution against phosphate-buffered saline

  • We stress that according to the method used [20], the PO42Ϫ concentration in the stock solution of lithostathine was 10 times the level required for complete inhibition of Ca2ϩ incorporation into calcite crystals

Read more

Summary

Introduction

Lithostathine (pancreatic stone protein, PSP) or Reg protein is a 144-residue glycoprotein synthesized by the exocrine pancreas [1, 2]. We performed competitive adsorption experiments to determine the affinity of lithostathine to calcite crystals, as compared with an amorphous phase (glass), using BSA as a control. Inhibitory Effects Due to Contaminants Potentially Present in the Lithostathine Solution and Effects of Components of Pancreatic Juice— The protein used in Ref. 13 was prepared according to Ref. 20.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call